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PURPOSE. To investigate 1-cys peroxiredoxin (1-cysPrx) expres-
sion during the corneal wound-healing process after PRK and
the effect of growth factors on 1-cysPrx expression in cultured
bovine keratocytes (BKs).
METHODS. Rat corneas were excised at 4 hours, 12 hours, 1 day,
3 days, and 7 days after PRK. Expression of 1-cysPrx in the
corneas was examined by immunohistochemical, Northern
blot, and immunoblot analyses. Keratocytes were isolated from
bovine corneas and subcultured to study the effects of TGF-1,
keratinocyte growth factor (KGF), hepatocyte growth factor
(HGF), platelet-derived growth factor (PDGF), and H2O2 on
1-cysPrx expression at different concentrations and time inter-
vals. Generation and proliferation of intracellular reactive ox-
ygen species (ROS) in cultured BKs stimulated by these growth
factors were measured by the DCF (2,7-dichlorofluorescein)
assay, the CCK-8 assay, and immunoblot analysis with a poly-
clonal proliferating cell nuclear antigen (PCNA) antibody, re-
spectively.
RESULTS. Intense staining of 1-cysPrx was observed in the epi-
thelia and the anterior stromas of wounded corneas 4 hours
after PRK and had extended to the entire stroma by day 3. By
day 7, the expression almost returned to nonsurgical control
level in epithelia, although notable expression was still detect-
able in the stroma. Concomitant augmentation of 1-cysPrx
mRNA and protein was seen in the corneas at 12 hours to 7
days. Growth factor treatment in cultured BKs resulted in
1-cysPrx induction in a dose- and time-dependent manner.
Growth factor–stimulated cells showed strong DCF fluores-
cence and increased proliferation during a 24-hour incubation,
during which an upregulation of 1-cysPrx occurred.
CONCLUSIONS. These observations provide new information for
the regulation of 1-cysPrx expression during the corneal
wound-healing process. (Invest Ophthalmol Vis Sci. 2005;46:
2396–2403) DOI:10.1167/iovs.05-0107
The cornea is a transparent tissue that consists of threecellular layers: epithelial, stromal, and endothelial. It func-
tions as the primary optical component and as an initial barrier
to tears and intraocular environments. To correct myopia and
astigmatism, the refractive power of the eye can be changed by
removing corneal tissue with a 193-nm excimer laser in a
technique known as photorefractive keratectomy (PRK).1,2
Once the corneal epithelium is damaged by trauma or refrac-
tive surgery, a series of wound-healing processes begins, with
cytokine-mediated interactions between epithelial cells and
keratocytes. The initial stage of wound healing in the cornea
involves apoptosis of the keratocytes, which occurs in re-
sponse to the release of interleukin (IL)-1, Fas/Fas ligand, or
tumor necrosis factor (TNF)- by the injured epithelium.3–5
After apoptosis, the remaining keratocytes begin to proliferate
and migrate into the area of the healing wound, which may
lead to myofibroblast differentiation.6,7 Reactivation and re-
population of keratocytes may affect surgical outcomes, includ-
ing corneal opacity and myopic regression. To prevent post-
operative complications, researches have attempted to
regulate the growth factors and their receptors that are respon-
sible for wound healing after the injury. Also, the development
of drugs designed to control apoptosis and proliferation is in
progress. However, little is known about the genes that par-
ticipate in the wound-healing process, including apoptosis,
proliferation, and differentiation.
The peroxiredoxins (Prx), a relatively new family of antiox-
idant enzymes, catalyze the reduction of a broad spectrum of
peroxides through conserved cysteine residues.8–10 Of the six
mammalian Prx enzymes, five (2-cysPrx and Prx types I
through V) contain two reactive cysteines and use thioredoxin
as a reductant. By contrast, 1-cysPrx (Prx VI) is the only mem-
ber that has a single conserved cysteine in the peroxide reduc-
tion active site.11,12 1-cysPrx has been isolated from bovine
ciliary body,13,14 rat olfactory epithelium,15 and rat and bovine
lung.16,17 Overexpression of 1-cysPrx can protect NCI-H441
cells against phospholipid peroxidation-mediated membrane
damage,18 whereas the accumulation of phospholipid hy-
droperoxide and apoptosis of lung epithelial cells occur when
endogenous expression is blocked by treatment with an anti-
sense oligonucleotide to 1-cysPrx.19
The presence of 1-cysPrx is distributed throughout all ocu-
lar tissues, including the cornea.20 However, its physiological
function in the eye remains uncertain. In the present study, we
investigated the levels of 1-cysPrx expression in rat corneas
during the wound-healing process that follows PRK. We also
examined the effect of growth factors on the expression of this
protein in cultured bovine keratocytes (BKs). Growth factors
were chosen for study because they are expressed in various
corneal cells and play key roles in corneal wound healing. The
results provide new information for the regulation of 1-cysPrx
expression during the corneal repair process, thereby contrib-
uting to our understanding of Prx proteins as multifunctional
enzymes which are not limited to their peroxidase activity.
MATERIALS AND METHODS
Fetal bovine serum (FBS), Dulbecco’s modified Eagle’s medium
(DMEM), Hanks’ balanced salt solution (HBSS), phosphate-buffered
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saline (PBS), trypsin-EDTA, and penicillin-streptomycin were pur-
chased from Life Technologies (Gaithersburg, MD). TGF-1, hepato-
cyte growth factor (HGF), platelet-derived growth factor (PDGF), and
keratinocyte growth factor (KGF) were from R&D Systems (Minneap-
olis, MN). Mouse monoclonal anti--actin and H2O2 were obtained
from Sigma-Aldrich (St. Louis, MO). Bovine polyclonal proliferating cell
nuclear antigen (PCNA) antibody was obtained from Chemicon (Te-
mecula, CA). Polyclonal 1-cysPrx antibody and bovine 1-cysPrx cDNA
clone were generously provided by Aron B. Fisher (Institute for Envi-
ronmental Medicine at the University of Pennsylvania Medical Center,
Philadelphia, PA). All chemicals (biotechnology grade) were purchased
from Amresco, Inc. (Solon, OH).
Photorefractive Keratectomy
Animal care and experimental procedures were conducted according
to the ARVO Statement for the Use of Animals in Ophthalmic and
Vision Research. Forty adult Sprague-Dawley male rats (250 g) were
anesthetized by intramuscular injection of ketamine (20 mg/kg) and
xylazine (10 mg/kg). After a drop of proparacaine, transepithelial PRK
(4-mm optical zone, 10 D) was performed on the right eye with a
flying spot excimer laser (Technolas 217z; Bausch & Lomb Surgical,
Munich, Germany). After excimer laser treatment, ofloxacin ointment
was applied. At 4 hours, 12 hours, 1 day, 3 days, and 7 days after PRK,
eight rats were randomly selected and euthanatized. Eyes were enu-
cleated and rinsed with cold PBS twice. The corneas were subse-
quently excised under an operating microscope, immediately frozen at
80°C until RNA and protein extraction, or fixed overnight in 4%
paraformaldehyde in PBS for immunohistochemical analysis. At each
time point, the left eyes were used as the control.
Immunohistochemistry
Paraffin-embedded sections were prepared from fixed tissues and
mounted on microscopic slides. Slides were deparaffinized and rehy-
drated with xylene and a graded series of ethanol. Sections were
stained by sequential incubation with 1-cysPrx antibody (1:600 dilution
in PBS containing 0.3% Triton X-100 and 3% bovine serum albumin)
followed by incubation in Texas red–conjugated goat anti-rabbit IgG
(diluted 1:1000 in the same buffer). After extensive washes in PBS with
0.3% Triton X-100 and in PBS, the sections were air dried, and cover-
slips were sealed with aqueous mounting medium. As a control for
nonspecific binding, nonimmune serum (diluted 1:600) was substi-
tuted for the primary antibody. All sections were photographed with
an inverted microscope (DMIRE2; Leica, Heidelberg, Germany)
equipped with a confocal laser scanning system (TSC-SP2; Leica). For
quantitation, we collected the fluorescent images with a single rapid
scan with identical parameters (such as brightness and contrast) for
each sample.
Bovine Keratocyte Culture
Fresh bovine eyeballs from a local abattoir were soaked in 5% povidone
iodide solution for 10 minutes and washed three times with PBS. The
epithelium and endothelium were removed manually from the cornea,
and the stroma was minced into pieces of 5 mm3 Stromal explants
were cultured in DMEM supplemented with 10% FBS and an antibiotic
mixture at 37°C in a humidified 5% CO2 atmosphere. Keratocytes were
allowed to migrate from the explants to the surface of culture plates.
The cells reached confluence within 20 days. After the organs were
discarded, the cells were detached and subcultured in 35-mm dishes.
Cells from cultures between the third and sixth passage were used in
the following experiments.
For the experiments involving growth factor or H2O2 exposure,
5  105 keratocytes were seeded on a 35-mm culture plate and grown
for 24 hours in standard growth conditions. Cells were gradually
deprived of serum by incubation in 1% FBS overnight, followed by
incubation in serum-free medium for 3 hours before use. These serum-
starved cells were treated with various concentrations of TGF-1 (2–20
ng/mL), KGF (2–20 ng/mL), HGF (2–20 ng/mL), PDGF (5–100 ng/mL),
or H2O2 (25–75 M) and incubated for 12 hours. Cells were also
exposed to fixed concentrations of growth factors and incubated for
the indicated times. The concentrations of growth factors and the time
points used in this study fell well within the range used in other studies
examining growth factor–induced reactive oxygen species (ROS) gen-
eration and proliferation in multiple cell types.21–24
Immunoblot Analysis
Frozen corneas (two for each time point) or growth factor–treated
keratocytes were disrupted with lysis buffer (25 mM Tris-HCl [pH 8.0],
1 mM EDTA, 1 mM EGTA, 2 mM dithiothreitol [DTT], 10% glycerol, 1%
Triton X-100, and complete protease inhibitor cocktail). The extracts
were homogenized by sonication and centrifuged at 10,000g for 20
minutes at 4°C. Protein concentrations were determined with a pro-
tein assay (DC Protein Assay; Bio-Rad, Hercules, CA). Supernatants
containing 20 g of proteins were separated by 12% SDS-PAGE and
then transferred onto nitrocellulose membranes (Amersham Bio-
sciences, Piscataway, NJ). The blot was probed with polyclonal
1-cysPrx antibody (1:3000 dilution) and horseradish-peroxidase–con-
jugated goat anti-rabbit IgG (1:5000 dilution; Jackson ImmunoResearch
Laboratory, West Grove, PA), followed by detection with enhanced
chemiluminescence (ECL; Santa Cruz Biotechnology, Inc., Santa Cruz,
CA) and quantitation by densitometric scanning of the x-ray film with
a fluorescence imager (FluorS Multi-Imager; Bio-Rad). The membrane
was then washed with stripping solution (62.5 mM Tris-HCl [pH 6.8]
100 mM -mercaptoethanol, and 2% SDS) at 55°C and reprobed with
monoclonal -actin antibody (1:10,000 dilution) to normalize for pro-
tein loading.
Northern Blot Analysis
Total RNA was extracted from the corneas, or from growth factor– or
H2O2-treated keratocytes using a kit (RNeasy mini kit; Qiagen, Valen-
cia, CA) according to the manufacturer’s instructions. Total RNA (5 g)
was separated by electrophoresis on a 1% agarose gel containing
formaldehyde, then transferred onto a nylon membrane (Schleicher &
Schuell, Keene, NH) by capillary action and hybridized to a 32P-labeled
bovine 1-cysPrx cDNA probe generated by random priming (Amer-
sham Biosciences). After a high-stringency wash, the membrane was
exposed to x-ray film with an intensifying screen at70°C for 14 hours
and quantitated using the same method. To normalize for loading, the
membrane was stripped of the 1-cysPrx probe, re-hybridized with a
32P-labeled glyceraldehyde-3-phosphate dehydrogenase (GAPDH)
cDNA probe, and re-exposed to x-ray film.
DCFH-DA Assay for Intracellular Reactive
Oxygen Species
BKs were seeded at a density of 1  104 cells per well in a 96-well
culture plate and were gradually deprived of serum in phenol-red–free
DMEM. Cells were then washed once with HBSS and loaded with 50
M DCFH-DA (2,7-dichlorofluorescein diacetate; Molecular Probes,
Inc., Eugene, OR) in this buffer for 15 minutes. Cells were subse-
quently washed twice with HBSS and stimulated with growth factors
(10 ng/mL of TGF-1, KGF, HGF, or PDGF) or treated with 50 M
H2O2 as a positive control for 30 minutes at 37°C. Intracellular fluo-
rescence was measured with a microplate fluorometer (Molecular
Devices Corp., Sunnyvale, CA) with an excitation of 485 nm and an
emission of 538 nm.
Cell Proliferation Assay
The effect of growth factors on the proliferation of BKs was examined
by a colorimetric cell-counting kit (CCK-8; Dojindo Laboratories, Ku-
mamoto, Japan) assay according to the manufacturer’s instructions.
Cells were cultured in a 96-well plate and stimulated as described
earlier for 12 and 24 hours. Cells were then treated with 10 L CCK-8
solution/well and incubated for 2 hours at 37°C. The amount of
formazan dye generated by cellular dehydrogenase activity was mea-
IOVS, July 2005, Vol. 46, No. 7 1-Cys Peroxiredoxin in Stromal Wound Healing after PRK 2397
sured by absorbance at 450 nm with a microplate fluorometer. Absor-
bances were converted to percentages for comparison with the un-
treated control. The expression level of PCNA in the stimulated cells
was also evaluated by immunoblot analysis with the appropriate anti-
body.
Data Analysis
The data are expressed as the mean  SE. Statistical analyses were
performed with Student’s t-test. The level of significance was consid-
ered to be P  0.05.
RESULTS
1-cysPrx Expression in Rat Corneas after PRK
Levels of both 1-cysPrx mRNA and protein increased in rat
corneas within 12 hours of PRK (Fig. 1). Specifically, expres-
sion reached its highest level (200%) between 1 and 3 days
after PRK. An apparent decrease in expression occurred on day
7, but was still high compared with the control corneas.
Immunohistochemical Detection of 1-cysPrx in
Rat Corneas after PRK
As measured by immunofluorescence, expression of 1-cysPrx
was detectable in the epithelium, but was low in the stroma of
the nonsurgical control corneas (Fig. 2A). As early as 4 hours
after the injury, intense 1-cysPrx signal was observed in the
epithelium and the anterior portion of the stromal wound area
(Fig. 2B). At 12 hours, immunoreactivity was extended into the
central stromal region (Fig. 2C). The number of 1-cysPrx-
positive keratocytes significantly increased throughout the
stroma on days 1and 3 (Figs. 2D, 2E). It is also noteworthy that
strong fluorescence was present in the inner layer of the
epithelium, corresponding to proliferating cells. By day 7, the
expression of 1-cysPrx had almost returned to control levels in
the epithelium, although 1-cysPrx-positive keratocytes were
still present in the stroma (Fig. 2F). 1-cysPrx-positive cells were
not detected in the negative control (Fig. 2G).
Effect of TGF-1 on 1-cysPrx Expression in BKs
We examined the effect of TGF-1 on 1-cysPrx expression in
cultured BKs. Serum depletion had no significant effect on
1-cysPrx expression during the experimental incubation peri-
ods (data not shown). Keratocytes were exposed to TGF-1 at
concentrations of 2 to 20 ng/mL for 12 hours. There was a
concentration-dependent increase in 1-cysPrx expression
within 8 ng/mL (Fig. 3A). Treatment with 8 ng/mL TGF-1
resulted in a time-dependent induction of the mRNA and pro-
tein, with a significant increase noted at 6 hours and a further
increase up to 24 hours (Fig. 3B). These increases were statis-
tically significant compared with the untreated control kerato-
cytes (P  0.05).
Effect of KGF on 1-cysPrx Expression in BKs
Because 1-cysPrx was identified as a highly inducible gene by
KGF in human skin cells,25 we also investigated whether
1-cysPrx was upregulated by KGF in keratocytes. The cells
treated with 2 to 20 ng/mL KGF for 12 hours showed that
induction was achieved in a dose-dependent manner, with the
maximum level of 1-cysPrx expression at 20 ng/mL (Fig. 4A).
With 8 ng/mL KGF, mRNA levels increased by 100% at 9
hours and 250% at 24 hours relative to the untreated control.
Meanwhile, the protein level increased by 200% at 9 hours
and remained constant between 9 and 24 hours (Fig. 4B).
These changes were statistically significant (P  0.05).
Effect of HGF on 1-cysPrx Expression in BKs
To determine the effect of HGF on 1-cysPrx expression, ker-
atocytes were exposed to 2 to 20 ng/mL of HGF for 12 hours.
At 5 ng/mL, HGF increased 1-cysPrx mRNA and protein by
50% and 100%, respectively (Fig. 5A). There were no fur-
ther increases in expression with higher concentrations. A
time course study with 5 ng/mL showed a 25% increase in
expression at 3 hours, followed by gradual increases (up to
100%) during longer incubations (Fig. 5B).
Effect of PDGF on 1-cysPrx Expression in BKs
To evaluate the effect of PDGF on the expression of 1-cysPrx,
cultured BKs were treated with PDGF at concentrations of 5 to
100 ng/mL for 12 hours. The expression of both mRNA and
protein increased in response to PDGF doses as low as 5 ng/mL
and also increased in a dose-dependent manner (Fig. 6A).
Treatment with 10 ng/mL resulted in a time-dependent induc-
tion of expression, with a significant increase noted at 6 hours
and an even further increase noted at 24 hours (Fig. 6B). There
was no increase in mRNA beyond 15 hours, but a gradual
increase in protein was observed.
Intracellular ROS Generation Stimulated by
Growth Factors in BKs
The generation of ROS has been detected in nonphagocytic
cells stimulated by various cytokines.26 Therefore, we assessed
the production of intracellular generation of ROS in BKs stim-
ulated by each growth factor, by using the oxidation-sensitive
FIGURE 1. Expression of 1-cysPrx in rat corneas after PRK as detected
by Northern (A) and immunoblot (B) analyses. Corneas that were
obtained from rats between 4 hours and 7 days after PRK were
evaluated. (A) Changes in 1-cysPrx mRNA levels, as analyzed by North-
ern blot. (B) Changes in protein levels, as analyzed by immunoblot. (C)
Individual data were quantified as densitometry units and normalized
with GAPDH (for mRNA) or actin (for protein). Data expressed as
percentages (relative to the control) and are the mean  SE of results
in three separate rat corneas at each time point. *P  0.05 compared
with the nonsurgical control.
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fluorescent probe DCFH-DA. Levels of DCF fluorescence in-
creased by 40% in response to growth factors, comparable
with that of 50 M H2O2 exposure (Fig. 7A). To examine the
ROS as inducers for 1-cysPrx expression, BKs were exposed to
H2O2 at concentrations of 25 to 75 M for 12 hours, which had
no effect on the release of lactate dehydrogenase (data not
shown). There was a concentration-dependent increase in
1-cysPrx mRNA expression up to 160% (Fig. 7B).
1-cysPrx Induction in Proliferating BKs
Stimulated by Growth Factors
To observe the augmented presence of 1-cysPrx in actively
proliferating cells, we first examined the effect of growth
factors on cellular proliferation by using a CCK-8 assay. As
shown in Figure 8A, there were no changes in the proliferative
rate of untreated control cells during a 12 hour or 24 hour
incubation due to serum starvation, whereas significant (P 
0.05) increases were present in TGF-1-, KGF-, and PDGF-
stimulated cells. The effect HGF was significant at 24 hours,
but not at 12 hours. Proliferation was confirmed by an immu-
noblot for PCNA, an excellent marker for mitogenic activation.
Consistent with results of the CCK-8 assay, stimulated cells
produced markedly higher levels of immunoreactive PCNA at
24 hours (Fig. 8B). PDGF induced PCNA the most (400%),
followed by TGF-1 (200%), KGF (60%), and HGF (40%).
The response of 1-cysPrx toward each growth factor was
similar to that of PCNA, which were 300% by PDGF, 200%
by TGF-1, 150% by KGF, and 80% by HGF, respectively.
DISCUSSION
The present study addressed the hypothesis that 1-cysPrx plays
a major role in cellular response to injury by evaluating the
levels of 1-cysPrx expression in an in vivo system. Because
changes in immunoreactive 1-cysPrx in the stroma after PRK
were dramatic (compared with those in the epithelium) and
were maintained through the entire repair period, our subse-
quent studies to determine the effect of growth factors on
1-cysPrx expression were performed using cultured BKs.
Various growth factors have been detected in the cornea,
where they play unique and important roles in homeostasis
and wound-healing regulation.27,28 For example, expression
levels of epidermal growth factor (EGF), HGF, KGF, and their
receptor mRNAs were low in unwounded mouse corneas.
After wounding, however, the growth factor mRNA expression
was markedly upregulated in the keratocytes, even after clo-
sure of the epithelial defect.29 In stroma and epithelium, the
profile of the increase in 1-cysPrx protein after PRK essentially
coincided with those of the growth factors, which suggests
that de novo synthesis of 1-cysPrx may play an important role
FIGURE 2. 1-cysPrx immunofluores-
cence in rat corneas after PRK. The
time points were 4 hours (B), 12
hours (C), day 1 (D), day 3 (E), and
day 7 (F) after PRK or before PRK
(A). Corneas that were exposed to
rabbit nonimmune serum instead of
primary antibody were used as the
negative control (G). Fluorescent im-
ages were taken by a confocal micro-
scope. Magnification, 400.
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in the mechanism of corneal wound healing. Previous studies
have also shown an induction of 1-cysPrx after cutaneous
injuries in mice, similar to that seen for KGF.30 Expression was
particularly abundant in the hyperproliferative keratinocytes at
the wound’s edge, suggesting an important role of the enzyme
during the repair process. We monitored changes in 1-cysPrx
expression in cultured BKs treated with TGF-1, HGF, KGF, or
PDGF, resulting in an increase in expression in a dose- and
time-dependent manner (Figs. 3, 4, 5, 6). Augmented expres-
sion was obvious in proliferating keratocytes during a 24-hour
incubation with these growth factors (Fig. 8), suggesting the
involvement of 1-cysPrx in cell proliferation. It is believed that
FIGURE 3. Effect of TGF-1 on the expression of 1-cysPrx in BKs.
Dose effect (A) and the time course studies for the effect of TGF-1 on
1-cysPrx expression (B). (A) Cells were treated with TGF-1 (2–20
ng/mL) for 12 hours and analyzed by Northern blot (for mRNA) and
immunoblot (for protein), using GAPDH and actin as loading standards,
respectively. (B) Cells were treated with 8 ng/mL TGF-1 and har-
vested at times between 1 and 24 hours, followed by Northern and
immunoblot analyses. Individual data were quantified as densitometry
units and are presented as a percentage of the control (without treat-
ment or time 0). Data are the mean  SE of results in three indepen-
dent experiments. *P  0.05 compared with the control.
FIGURE 4. Effect of KGF on the expression of 1-cysPrx in BKs. Dose
effect (A) and time course studies for the effect of KGF on 1-cysPrx
expression (B). (A) Cells were treated with KGF at various concentra-
tions for 12 hours and analyzed by Northern blot for mRNA and by
immunoblot for protein using GAPDH and actin as loading standards,
respectively. (B) Cells were treated with 8 ng/mL KGF and harvested
at times between 1 and 24 hours, then subjected to Northern and
immunoblot analyses. Individual data were quantified as densitometry
units and are presented as a percentage of the control (without treat-
ment or time 0). Data are the mean  SE of results in three indepen-
dent experiments. *P  0.05 compared with the control.
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KGF and HGF induce cellular proliferation and migration in the
corneal tissues as paracrine mediators, whereas PDGF acts
through both autocrine and paracrine mechanisms.8 The most
intriguing result is the mitogenic response of keratocytes to
TGF-1, which acts as an autocrine mediator. TGF- has been
regarded as a multifunctional cytokine with the capacity to
promote or inhibit cell proliferation, depending on cell type.
TGF-1 significantly stimulates cell proliferation of cultured
bovine and rabbit keratocytes.23,31
Many mammalian cells produce intracellular ROS in re-
sponse to various cytokines, such as IL-1, TNF-, IFN-, TGF-,
PDGF, HGF, KGF, EGF, and basic fibroblast growth factor.26
The detection of intracellular ROS and the induction of
FIGURE 5. Effect of HGF on 1-cysPrx expression in BKs. (A) Dose
effects of HGF. Cells were treated with HGF (2–20 ng/mL) for 12 hours
and 1-cysPrx expression was analyzed by Northern blot and immuno-
blot. (B) Time course of HGF effects on 1-cysPrx expression. Cells
were treated with 5 ng/mL HGF for 1 to 24 hours and harvested at
various times for Northern and immunoblot analysis. Expression of
1-cysPrx mRNA and protein were normalized to GAPDH and actin and
are presented as a percentage of the control (without treatment or
time 0). Data are the mean  SE of results in three independent
experiments. *P  0.05 compared with control.
FIGURE 6. Effect of PDGF on 1-cysPrx expression in BKs. (A) Dose
effects of PDGF. Cells were treated with PDGF (5–100 ng/mL) for 12
hours, and 1-cysPrx expression was analyzed by Northern blot and
immunoblot analyses. (B) Time course of PDGF effects on 1-cysPrx
expression. Cells were treated with 10 ng/mL PDGF for 1 to 24 hours
and harvested at various times for Northern and immunoblot analysis.
Expression of 1-cysPrx mRNA and protein were normalized to GAPDH
and actin and are presented as a percentage of the control (without
treatment or time 0). Data are the mean  SE of results in three
independent experiments. *P  0.05 compared with the control.
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1-cysPrx in BKs during growth factor and H2O2 exposure (Fig.
7) imply that the rapid removal of ROS and its production for
signal cascades are necessary for the maintenance of redox
homeostasis, for which 1-cysPrx may be responsible. Previ-
ously, transient overexpression of Prx I or II, members of the
2-cysPrx family, in A431 cells or NIH 3T3 cells resulted in
reduced intracellular H2O2 levels generated by EGF or PDGF.
Moreover, the activation of NF-B exposed to the extracellular
addition of H2O2 or TNF- was attenuated by Prx II overex-
pression.21
Excimer laser ablation produces oxygen free radicals. This
is probably due to UV radiation, polymorphonuclear cell infil-
tration, and thermal increase.32,33 Previous investigators have
studied the relative importance of antioxidant enzymes in the
ability of corneal tissues to tolerate oxidative stress, focusing
primarily on classic antioxidant enzymes, such as superoxide
dismutase (SOD)34 and glutathione peroxidase (GPx).35 How-
ever, the activities of these enzymes decreased in rabbit cor-
neas after different refractive corneal surgery,36,37 speculating
that another antioxidant enzyme may be necessary to compen-
sate for the reduction in SOD and GPx levels. 1-cysPrx expres-
sion increased in corneal tissues as early as 4 hours after PRK
and remained high until day 7 (Figs. 1, 2), suggesting that
1-cysPrx may be an important enzyme involved in migration,
proliferation, and differentiation, which occur during corneal
wound healing. It is also possible that 1-cysPrx may function as
an antioxidant enzyme to reduce the accumulation of ROS
caused by excimer laser or growth factors, thus preventing
apoptotic cell death.
In human lens epithelial cells, 1-cysPrx was induced by lens
epithelium–derived growth factor to protect cells from oxida-
tive stress.38 Other studies using the same cell line showed that
overexpression of 1-cysPrx prevents hyperglycemia-mediated
apoptosis, a result of osmotic and oxidative stress.39 Recently,
gene-targeted mice without 1-cysPrx have shown increased
sensitivity to paraquat-induced oxidative injury, which was not
replaced by other Prxs and antioxidant enzymes.40 Taken
along with the data in the present study, we postulate that
1-cysPrx may play divergent roles in the eye that are associated
with various biological processes, such as oxidant detoxifica-
tion, proliferation, and differentiation. These are functions that
are not met by catalase, SOD, or GPx.
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FIGURE 7. Measurement of growth factor–induced ROS generation by
DCF fluorescence (A) and effect of H2O2 treatment on 1-cysPrx mRNA
expression (B) in BKs. (A) Cells were treated with each growth factor
(10 ng/mL) or 50 M H2O2 as a positive control for 30 minutes.
Generation of ROS was determined by DCF fluorescence. Each data set
represents relative values for untreated cells and means  SE for three
independent experiments. *P  0.05 compared with the control. (B)
Representative Northern blot for 1-cysPrx expression in H2O2-exposed
BKs. Cells were treated with H2O2 at various concentrations for 12
hours and analyzed by Northern hybridization. Expression of 1-cysPrx
mRNA was normalized to that for GAPDH, as indicated by the ratio
below each lane.
FIGURE 8. Effect of growth factors on cellular proliferation and the
induction of 1-cysPrx in BKs. (A) Proliferative response to each growth
factor. Cells were stimulated with 10 ng/mL of various growth factors
for 12 hours and 24 hours. Growth was then measured based on
formazan dye production in a CCK-8 assay. Each data set represents a
relative percentage of the control (without treatment). Data are the
mean  SE of three independent experiments. *P  0.05 compared
with the control. (B) Representative immunoblot for PCNA and
1-cysPrx expression. Growth factor–stimulated cells were harvested
after 24 hours and analyzed by immunoblot using PCNA and 1-cysPrx
antibodies. Expression of PCNA and 1-cysPrx proteins were normal-
ized to that for actin, as indicated by the ratio below each lane.
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